EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Association Between Ursodeoxycholic Acid and Clinical Outcomes in Patients With COVID-19 Infection: Population-Based Cohort Study

Hyunjun Lee iD, Min Gul Kim iD, Sang Woo Yeom iD, Sang Jae Noh iD, Cho Yun Jeong iD, Min Ji Kim iD, Min Gu Kang iD, Ji Hoon Ko iD, Su Cheol Park iD, Hyeok Tae Kweon iD, Sang Il Sim iD, Hyun Lee iD und 2 weitere

JMIR Public Health and Surveillance · 07.10.2024 · 10 · e59274

DOI: 10.2196/59274 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JMIR Public Health and Surveillance, online erschienen am 07.10.2024. Verfasst von Hyunjun Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Jeonbuk National University Medical School, Jeonju, Republic of Korea, Jeonju, Republic of K…. Hauptthemen laut MEDLINE: Ursodeoxycholic Acid, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several studies have investigated the relationship between ursodeoxycholic acid (UDCA) and COVID-19 infection. However, complex and conflicting results have generated confusion in the application of these results.

Objective

We aimed to investigate whether the association between UDCA and COVID-19 infection can also be demonstrated through the analysis of a large-scale cohort.

Methods

This retrospective study used local and nationwide cohorts, namely, the Jeonbuk National University Hospital into the Observational Medical Outcomes Partnership common data model cohort (JBUH CDM) and the Korean National Health Insurance Service claim–based database (NHIS). We investigated UDCA intake and its relationship with COVID-19 susceptibility and severity using validated propensity score matching.

Results

Regarding COVID-19 susceptibility, the adjusted hazard ratio (aHR) value of the UDCA intake was significantly lowered to 0.71 in the case of the JBUH CDM (95% CI 0.52-0.98) and was significantly lowered to 0.93 (95% CI 0.90-0.96) in the case of the NHIS. Regarding COVID-19 severity, the UDCA intake was found to be significantly lowered to 0.21 (95% CI 0.09-0.46) in the case of JBUH CDM. Furthermore, the aHR value was significantly lowered to 0.77 in the case of NHIS (95% CI 0.62-0.95).

Conclusions

Using a large-scale local and nationwide cohort, we confirmed that UDCA intake was significantly associated with reductions in COVID-19 susceptibility and severity. These trends remained consistent regardless of the UDCA dosage. This suggests the potential of UDCA as a preventive and therapeutic agent for COVID-19 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ursodeoxycholic AcidCOVID-19HumansMaleFemaleMiddle AgedRetrospective StudiesRepublic of KoreaAdultAgedCohort StudiesCOVID-19 Drug TreatmentTreatment OutcomeSeverity of Illness Index

Stichwörter der Autor:innen

COVID-19CoronavirusCovid 19SARS-CoV-2UDCAclinicalcommon data modelpandemicpopulation-basedpopulation-based cohort studypropensity scorepublic healthretrospective cohort studyseverityursodeoxycholic acid

Substanzen

Ursodeoxycholic Acid

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Jeonbuk National University Medical School, Jeonju, Republic of Korea, Jeonju, Republic of Korea.
  • Department of Pharmacology, Jeonbuk National University Medical School, Jeonju, Republic of Korea, Jeonju, Republic of Korea.
  • Department of Medical Informatics, Jeonbuk National University Medical School, Jeonju, Republic of Korea, Jeonju, Republic of Korea.
  • Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea, Jeonju, Republic of Korea.
  • Big Data Center, Jeonbuk National University Hospital, Jeonju, Republic of Korea.
  • Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Hyunjun Lee, Min Gul Kim, Sang Woo Yeom, Sang Jae Noh, Cho Yun Jeong, Min Ji Kim, Min Gu Kang, Ji Hoon Ko, Su Cheol Park, Hyeok Tae Kweon, Sang Il Sim, Hyun Lee, Yeon Seok You, Jong Seung Kim

Zitieren

APA

Lee, H., Kim, M. G., Yeom, S. W., Noh, S. J., Jeong, C. Y., Kim, M. J., Kang, M. G., Ko, J. H., Park, S. C., Kweon, H. T., Sim, S. I., Lee, H., You, Y. S., & Kim, J. S. (2024). Association Between Ursodeoxycholic Acid and Clinical Outcomes in Patients With COVID-19 Infection: Population-Based Cohort Study. JMIR Public Health and Surveillance, 10, e59274. https://doi.org/10.2196/59274

Vancouver

Lee H, Kim MG, Yeom SW, Noh SJ, Jeong CY, Kim MJ, et al. Association Between Ursodeoxycholic Acid and Clinical Outcomes in Patients With COVID-19 Infection: Population-Based Cohort Study. JMIR Public Health and Surveillance. 2024;10:e59274. doi:10.2196/59274

BibTeX
@article{Lee2024,
  author = {Lee, Hyunjun and Kim, Min Gul and Yeom, Sang Woo and Noh, Sang Jae and Jeong, Cho Yun and Kim, Min Ji and Kang, Min Gu and Ko, Ji Hoon and Park, Su Cheol and Kweon, Hyeok Tae and Sim, Sang Il and Lee, Hyun and You, Yeon Seok and Kim, Jong Seung},
  title = {Association Between Ursodeoxycholic Acid and Clinical Outcomes in Patients With COVID-19 Infection: Population-Based Cohort Study},
  journal = {JMIR Public Health and Surveillance},
  year = {2024},
  volume = {10},
  pages = {e59274},
  doi = {10.2196/59274}
}
Kostenlos starten →